FDA To Strengthen Generic Drug Program Which Will Streamline Generic Drug Approval Process

The US Food and Drug Administration (FDA) will bolster its generic drug program which should raise the number and range of generic drugs available to health care providers and consumers. Generic drugs tend to be cheaper than brand name drugs - fierce competition among generic makers has helped bring prices down, explains the FDA. The Generic Initiative for Value and Efficiency (GIVE) is aimed at streamlining and modernizing the FDA’s generic drug approval business. [click link for full article]

More: continued here

Filed under: Pharma Industry on October 5th, 2007